Latest News

Old Dominion Freight Line recently announced it will release its first-quarter 2026 results and host a webcasted conference call on April 29, 2026, following earlier quarters where earnings and revenue exceeded analyst expectations despite shipment volume pressures. The upcoming report will highlight whether the company’s strong pricing power can continue to offset weaker freight volumes and support profitability amid cautious economic commentary from management. We’ll now examine how Old...

Ripretinib filing puts Ono Pharmaceutical in focus Ono Pharmaceutical (TSE:4528) has drawn fresh attention after applying in Japan for manufacturing and marketing approval of ripretinib for advanced gastrointestinal stromal tumor following prior cancer chemotherapy. The filing is based on Phase 3 INVICTUS data, in which ripretinib extended progression free survival compared with placebo in heavily pretreated GIST patients. It follows approvals in more than 40 markets, including the U.S. and...

In the most recent quarter, GATX reported US$449 million in revenue, an 8.6% year-on-year increase that surpassed analyst expectations, but the company fell short of EBITDA estimates, creating a mixed picture for its latest results. This contrast between strong revenue growth and weaker-than-expected profitability highlights how cost pressures and margin performance are becoming central to how investors assess GATX’s railcar leasing operations. We’ll now examine how GATX’s revenue beat...

Zhong Ju Investment Group (SEHK:1959) has posted its FY 2025 first half numbers with revenue of C¥454.2 million and a net loss, reflected in basic EPS of C¥0.031, while the trailing twelve months show revenue of C¥958.6 million and a net loss of C¥53.4 million, or EPS of C¥0.106. Over recent halves, the company has seen revenue move from C¥738.0 million in 1H FY 2024 to C¥504.3 million in 2H FY 2024 and C¥454.2 million in 1H FY 2025, alongside net losses of C¥52.4 million, C¥37.4 million and...

China Harmony Auto Holding (SEHK:3836) has reported its FY 2025 first half with revenue of C¥9.6b and a basic EPS loss of C¥0.0077, setting a cautious tone around profitability at a current share price of C¥1.12. Over the past three reported halves, revenue has moved from C¥7.5b in 1H 2024 to C¥8.2b in 2H 2024 and now C¥9.6b in 1H 2025. Over the same periods, basic EPS losses have shifted from C¥0.0512 to C¥0.1447 and then to C¥0.0077, leaving investors to weigh thin margins against the...

Sotera Health (SHC) has attracted fresh attention after reporting fourth quarter net revenues of US$1.16b, up 5.7% year over year. The results beat consensus estimates and lifted earnings expectations among brokerage firms. See our latest analysis for Sotera Health. The strong fourth quarter update has come alongside a sharp shift in sentiment, with a 1-day share price return of 3.70% and 7-day share price return of 8.54% contrasting with a 90-day share price return decline of 15.70%...

What the latest results mean for WELL Health Technologies WELL Health Technologies (TSX:WELL) has drawn attention after releasing full year 2025 earnings, reporting CA$1.40b in sales alongside a net loss of CA$7.36m, and issuing 2026 revenue guidance of CA$1.55b to CA$1.65b. See our latest analysis for WELL Health Technologies. The full year 2025 results and 2026 revenue guidance arrive after a 1 year total shareholder return decline of 12.19% and a 5 year total shareholder return decline...

In late March 2026, Birkenstock reported its fiscal third-quarter 2025 results, highlighting 16% constant-currency revenue growth, margin improvement despite currency pressures, and reaffirmed full-year 2025 targets, while also announcing the acquisition of long-standing distributor Birkenstock Australia Pty. Ltd. in one of its largest markets. An interesting angle is how management plans to offset new US and EU tariffs through pricing and cost controls while bringing a key distributor fully...

Why this earnings release matters for Lingbao Gold Group (SEHK:3330) shareholders Lingbao Gold Group (SEHK:3330) reported full year 2025 sales of CN¥13,143.4 million and net income of CN¥1,543.15 million, with basic earnings per share from continuing operations of CN¥1.2076. See our latest analysis for Lingbao Gold Group. Lingbao Gold Group’s share price has been strong over multiple timeframes, with a 44.49% 90 day share price return and a very large 5 year total shareholder return, although...

Setting the Scene: China Xinhua Education Group’s Latest Numbers China Xinhua Education Group (SEHK:2779) has released its FY 2025 first half scorecard with revenue of C¥362.6 million and basic EPS of C¥0.159, against a current share price of HK$0.51. Trailing twelve month revenue stands at C¥654.9 million with EPS of C¥0.232. Over recent periods, the company has reported revenue of C¥355.7 million and EPS of C¥0.132 in 1H 2024, then revenue of C¥292.4 million and EPS of C¥0.073 in 2H 2024,...

Wondering whether Adaptive Biotechnologies at around US$14.43 is still good value or already pricing in a lot of optimism? This article breaks down what the current share price might be implying. The stock has had a mixed run lately, with a 2.0% gain over the last week, a 10.5% decline over the last month, a 9.3% decline year to date, an 81.7% return over the past year and 71.2% over three years, while five-year returns stand at a 64.5% loss. Recent attention on Adaptive Biotechnologies has...

Alkane Resources (ASX:ALK) has secured an A$110 million revolving credit facility and an A$40 million contingent instrument facility with a syndicate of major Australian banks, following early repayment of its previous project finance facility. See our latest analysis for Alkane Resources. The new debt facilities arrive after a 7.97% year to date share price return and a 120.74% one year total shareholder return, with recent 30 day share price weakness and a 1 day pullback suggesting some...

Medtronic (MDT) is back in focus after fresh U.S. Food and Drug Administration clearance for its AI-enabled Stealth AXiS surgical system in cranial and ENT procedures, along with encouraging ALERT trial results for AI-driven cardiac care support. See our latest analysis for Medtronic. Despite the recent AI and FDA milestones, the 1 month share price return of 12.27% and year to date share price return of 10.40% show pressure building on the US$86.06 share price. At the same time, the 3 year...

Lucid Group (NasdaqGS:LCID) is cutting 319 jobs, about 12% of its workforce, as part of a cost reduction effort. The move is intended to improve efficiency and support progress toward gross margin targets. The company continues to face production challenges and depends heavily on funding linked to Saudi Arabia, which brings additional geopolitical risk. Lucid Group enters this restructuring phase after a difficult share price performance, with the stock at $9.56 and returns of 10.5% over...

Latest Results: Headline Numbers For FY 2025 Chu Kong Shipping Enterprises (Group) (SEHK:560) opened FY 2025 with first half revenue of HK$1.3b and basic EPS of HK$0.02, setting the tone for a period where investors are closely watching how earnings quality holds up against softer profitability. Over recent reporting periods the company has seen revenue move from HK$1.4b in 1H 2024 to HK$1.3b in 2H 2024 and HK$1.3b in 1H 2025, with basic EPS shifting from HK$0.06 to HK$0.04 and then HK$0.02...

Flowserve (NYSE:FLS) announced that the President of its Pumps Division has resigned, with leadership transition plans already in place. The company also disclosed the planned retirement of its Chief Accounting Officer, alongside identified successors and succession timing. These leadership moves are described as material corporate events, separate from earnings guidance, valuation, or price targets. Flowserve enters these leadership changes with the stock at $75.4 and a return of 53.3%...

If you are wondering whether Celestica's current share price reflects its true worth, you are not alone, especially after such an eye catching run in recent years. The stock last closed at $400.29, with returns of 9.7% over 30 days, a 4.1% decline over 7 days, a 3.5% decline year to date, and a 239.4% gain over 1 year, while the 3 year return is very large and the 5 year return is more than 35x. Recent coverage has focused on Celestica's long term share price performance and what that means...

Agile Group Holdings FY 2025 earnings snapshot Agile Group Holdings (SEHK:3383) has reported its FY 2025 first half numbers with revenue of C¥13.6b and a basic EPS loss of C¥1.59, keeping the spotlight firmly on profitability. The company has seen revenue move from C¥21.1b in 1H 2024 to C¥22.2b in 2H 2024 and then to C¥13.6b in 1H 2025, while basic EPS has stayed in loss-making territory between C¥1.49 and C¥1.92 per share over these periods. With trailing twelve month revenue at C¥35.8b set...

In recent days, more than 200 United Natural Foods (UNFI) warehouse workers voted unanimously to authorize a strike if contract talks fail and alleged unfair labor practices continue, raising the risk of distribution disruptions. At the same time, UNFI hired Alexis (Lex) Josephs as its first chief digital services officer to strengthen digital capabilities after a prior cyberattack. This combination of potential labor unrest and renewed focus on digital resilience highlights how employee...

Carnival Corporation & plc recently reported first-quarter 2026 results, with sales of US$2,142 million, revenue of US$6,165 million, and net income of US$258 million, and also announced a US$2.50 billion open-ended share repurchase program authorized by its Board of Directors on March 27, 2026. The shift from a net loss to positive earnings, alongside committing billions to buybacks, signals management’s confidence in the company’s financial position and future cash generation...

Yuexiu Property (SEHK:123) has reported its FY 2025 first half results with revenue of C¥47.6b and basic EPS of C¥0.34, setting the stage for a year where profitability and growth expectations are firmly in focus. The company has seen revenue move from C¥35.3b in 1H 2024 to C¥47.6b in 1H 2025, alongside EPS shifting from C¥0.45 to C¥0.34. Trailing twelve month EPS sits at C¥0.01 on revenue of C¥86.5b, giving investors a detailed read on how headline growth and earnings quality intersect. With...

AtkinsRéalis Group (TSX:ATRL) has been in focus after a series of contract wins and financing moves, including preferred consortium status on Québec City’s tramway systems work and a £98 million UK rail signalling upgrade mandate. See our latest analysis for AtkinsRéalis Group. Those contract wins and the CA$700 million debenture refinancing have arrived while the share price sits at CA$92.08, with a 90 day share price return of 3.93% and a 1 year total shareholder return of 30.84%. This...

Soft earnings didn't appear to concern RHÖN-KLINIKUM Aktiengesellschaft's ( ETR:RHK ) shareholders over the last week...

Wondering whether Santacruz Silver Mining is still priced attractively after its recent run, or if the easy gains are already gone? This article focuses squarely on what you are getting for the current share price. The stock recently closed at CA$11.34, with returns of 1.5% over 7 days, a 31.8% decline over 30 days, a 13.1% decline year to date, and a very large gain of about 7x over the past 5 years. Recent news coverage has highlighted Santacruz Silver Mining as a high returning name...